Home › SEC Filings › Insider Cluster Activity
Insider Cluster Activity
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| RXRX | CLUSTER | neutral | 2/10 | Three directors at Recursion Pharmaceuticals sold a total of $271K in open-market transactions over a 7-day window. The | Jun 5, 2026 |
| JAZZ | CLUSTER | bearish | 5/10 | A cluster of three Jazz Pharmaceuticals insiders sold $3.32M in stock over a one-week window, including the EVP & Chief | Jun 5, 2026 |
| EQ | CLUSTER | bearish | 5/10 | Three Equillium insiders, including the President/CSO, COO, and Principal Accounting Officer, sold a total of ~$975K in | Jun 5, 2026 |
| UTHR | CLUSTER | neutral | 2/10 | Three top insiders at United Therapeutics (CEO, CFO, General Counsel) sold a total of $391K in open-market shares over a | Jun 5, 2026 |
| INSM | CLUSTER | neutral | 2/10 | Five C-suite insiders at INSMED Inc, including the CEO and CFO, collectively sold $1.75M in open-market sales over a 7-d | Jun 5, 2026 |
| INSM | CLUSTER | neutral | 2/10 | Three top INSM insiders, CEO, CFO, and CMO, collectively sold $1.29M in open-market sales over a 7-day window. The total | Jun 5, 2026 |
| GNLX | CLUSTER | neutral | 2/10 | Two Genelux insiders (a Director and the Head of Regulatory) sold a total of $30K in open-market sales over a 7-day wind | Jun 4, 2026 |
| SMMT | CLUSTER | bullish | 5/10 | Both co-CEOs and the COO/CFO of Summit Therapeutics made open-market purchases totaling $3.28M on June 4, 2026, at ~$14. | Jun 4, 2026 |
| NBIX | CLUSTER | neutral | 3/10 | Four NBIX C-suite insiders sold a total of $4.93M in open-market shares over a 7-day window, with the largest sales by t | Jun 4, 2026 |
| NBIX | CLUSTER | neutral | 2/10 | Three C-suite officers at Neurocrine Biosciences sold a total of ~$2.73M in open-market shares within a 7-day window. Al | Jun 4, 2026 |
| SMMT | CLUSTER | bullish | 6/10 | Co-CEO Mahkam Zanganeh and COO/CFO Manmeet Singh collectively purchased $1.82M in open-market shares at ~$14.50 on June | Jun 4, 2026 |
| UTHR | CLUSTER | neutral | 3/10 | Three top executives at United Therapeutics (CEO, CFO, General Counsel) collectively sold $1.11M in open-market shares o | Jun 4, 2026 |
| ALKS | CLUSTER | neutral | 3/10 | Three Alkermes insiders, including the EVP R&D/CMO and VP Finance, sold a total of ~$1.15M in open-market sales over a 7 | Jun 4, 2026 |
| CORT | CLUSTER | neutral | 3/10 | Five Corcept Therapeutics insiders, including the CEO, CFO, and Chief Development Officer, sold a total of $6.91M in ope | Jun 4, 2026 |
| UTHR | CLUSTER | neutral | 2/10 | CEO Martine Rothblatt and CFO James Edgemond executed derivative exercises and sold a combined ~$1.0M in open-market sha | Jun 4, 2026 |
| SYRE | CLUSTER | neutral | 2/10 | CEO Turtle Cameron and CFO Scott Burrows sold a combined $372K in SYRE stock on June 1, 2026, at ~$69.40-$69.75. The CFO | Jun 3, 2026 |
| HALO | CLUSTER | neutral | 2/10 | CEO Helen Torley and a director sold a combined ~$214K in open-market shares on June 1, 2026, at ~$66/share. The CEO als | Jun 3, 2026 |
| EVMN | CLUSTER | bearish | 5/10 | Three top executives at Evommune (CEO, CFO, CLO) sold a combined $1.12M in open-market sales over a 5-day window, repres | Jun 3, 2026 |
| CORT | CLUSTER | neutral | 3/10 | Four CORT insiders, including the CEO, CFO, and two senior executives, sold a total of $5.50M in open-market shares with | Jun 3, 2026 |
| CORT | CLUSTER | bearish | 5/10 | Four Corcept Therapeutics insiders, including the CEO, CFO, and two other senior executives, sold a total of $5.50M in o | Jun 3, 2026 |
| CORT | CLUSTER | neutral | 4/10 | Three top executives at Corcept Therapeutics (CEO, CFO, and a senior officer) sold a total of $7.59M in open-market shar | Jun 3, 2026 |
| CORT | CLUSTER | neutral | 3/10 | CEO Joseph Belanoff sold $895K worth of CORT shares on June 1, and two other executives sold a combined $3.9M on May 27, | Jun 3, 2026 |
| EXEL | CLUSTER | neutral | 2/10 | Two Exelixis directors sold a total of ~$690K in open-market transactions over a 7-day window, representing ~0.006% of t | Jun 3, 2026 |
| LODE | CLUSTER | bullish | 5/10 | Two insiders at Comstock Inc. made open-market purchases totaling $71K in early June 2026, including CEO Corrado DeGaspe | Jun 3, 2026 |
| OTLK | CLUSTER | bullish | 7/10 | A significant insider buying cluster at Outlook Therapeutics, totaling $5.25M in open-market purchases, is dominated by | Jun 3, 2026 |
| ALEC | CLUSTER | neutral | 3/10 | CEO Arnon Rosenthal and CFO Neil Berkley sold a combined $210K in open-market sales on June 2, 2026, with the CEO alone | Jun 3, 2026 |
| JAZZ | CLUSTER | neutral | 3/10 | Three Jazz Pharmaceuticals insiders sold a total of $3.32M in open-market transactions over a 7-day window, including th | Jun 3, 2026 |
| MAZE | CLUSTER | bearish | 4/10 | Three Maze Therapeutics insiders sold a combined $1.20M in open-market stock over a 6-day window, including the CEO, Pre | Jun 3, 2026 |
| UTHR | CLUSTER | neutral | 2/10 | CEO Martine Rothblatt and CFO James Edgemond sold a combined ~$1.41M in UTHR shares over five trading days, entirely fro | Jun 3, 2026 |
| LQDA | CLUSTER | neutral | 3/10 | Three Liquidia Corp insiders sold a total of ~$1.32M in open-market transactions over a one-week window ending June 1, 2 | Jun 3, 2026 |